Lopinovir
Lopinovir is a protease inhibitor with antiviral activity against HIV.
Primary Characteristics
Molecular Weight: 444.44 · Non-proprietary name: doxicycline hyclate.

Pharmacokinetics
Distribution: Lopinovir has a plasma protein binding is 90%.
Elimination: it is metabolised via not hepatic, plasma half-life is 12-15hours, renal excretion is 30%faeces,23%uine.
Advertisement
Indications
Lopinovir is primarily indicated in conditions like Rocky mountain spotted fever, Trachoma, Urinary tract infection.
Contraindications
Lopinovir is contraindicated in conditions like Hypersensitivity.
Dosage
Lopinovir's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 400 mg | 400 mg | — | oral | |
| 400 mg | 400 mg | — | oral | take with food |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | ||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
The signs and symptoms that are produced after acute overdosage of Lopinovir are Pancreatitis.
Lopinovir is known to cause more or less tolerable side effects which are usually transient. These include Hypercholesterolemia.
Warnings / Precautions
Available Brands
Click on a strength to view available brands.
Multi-Ingredient Combinations
Drug Classification
- 1.6.5.2 — Antiretroviral drugs
Manufacturers
Manufacturers of Lopinovir in Pakistan: